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Abstract
Background: The ability to do online searches for health information has led to concerns that patients find the
results confusing and that they often lead to expectations for treatments that have little supportive evidence. At
the same time, the science of summarizing research evidence has advanced to the point where it is increasingly
possible to quantify treatment tradeoffs and to describe the balance between harms and benefits for individual
patients.
Discussion: Trustworthy clinical practice guidelines provide evidence-based recommendations to health care
practitioners based on assessments of study-level averages. In an effort to customize the use of evidence and
ensure that choices are consistent with their personal preferences, tools for patients have been developed.
Gradually, there is recognition that the audience for high quality evidence is much wider than merely health care
professionals – and that there is a case to be made for creating tools that translate existing evidence into tools to
help patients and clinicians work together to decide next steps.
Summary: We observe two processes occurring: first, is the recognition that decision making in healthcare requires
collaboration and deliberation, and second, to achieve this, we need tools designed to customize care at the level
of individuals.
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Background
Forbidding Dr. Google
In November 2014, the Flemish government paid the
Belgian Center of Evidence-Based Medicine to create a
video telling patients to avoid Google before going to see
their own doctor [1]. The reaction in social media was
predictable. It is too late to turn the tide. Patients visit
Google in increasing numbers: a phenomenon that is
not going to be influenced by one media campaign. Yet,
the underlying concern is valid enough. It is very diffi-
cult, if not impossible, to interpret the results of such
searches – where are the data we can trust, who gener-
ated the information, and where do the conflicts of
interest lie? Which of the thousands of URLs listed have
any degree of transparency about who generated the in-
formation, how did they do so, and what do they stand
to gain in some way by its use? To what extent can
patients rely on the experience of other patients or be
directed to good summaries of scientific evidence?
Should Google algorithms prioritize recognized sources
of high quality evidence summaries?
It was 40 years ago when Archie Cochrane wrote: “It
is surely a great criticism of our profession that we have
not organized a critical summary, by specialty or subspe-
cialty, adapted periodically, of all relevant randomized
control trials [2].” This observation led Iain Chalmers to
propose the Cochrane Collaboration, which has since
pioneered methods to produce high quality systematic
reviews. These systematic reviews have become the
cornerstones of evidence-based medicine and have
been increasingly used to develop clinical practice
guidelines [3]. Until recently, however, the majority of
guidelines were not rigorously developed. They were –
among many other limitations – compromised by the
conflicted interests of their panelists [4, 5]. Fortu-
nately, developments that include clear standards for
guidelines and innovative strategies to deal with conflict
of interest and appropriately engage patients in the
* Correspondence: glynelwyn@gmail.com
1The Dartmouth Institute for Health Policy and Clinical Practice, 37 Dewey
Field Road, Hanover, NH 03755, USA
Full list of author information is available at the end of the article
© 2015 Elwyn et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Elwyn et al. BMC Medicine  (2015) 13:199 
DOI 10.1186/s12916-015-0436-y
process are resulting in evidence that is increasingly
trustworthy [6, 7] – there is now more confidence that
the synthesis represents the most rigorous approach to
interpreting existing science.
However, guidelines have limitations, especially when
we consider the necessity to customize treatments and
decisions. It is not only difficult to find guidelines, it is
also difficult to know which ones are of high quality.
Guidelines can only make recommendations for typical
patients, and cannot ensure that individual values and
preferences are accounted for in the ultimate manage-
ment decisions.
Going beyond clinical practice guidelines
Despite the enormous investment in guideline produc-
tion, only a limited number have been successfully tai-
lored so that they are optimally useful to clinicians and
very few, if any, have been tailored for optimal useful-
ness to patients. Clinicians have the task of tailoring evi-
dence to individuals – to people at different ages and
with different sets of problems, concerns, preferences,
and priorities. Many existing clinical practice guidelines
do not support this task despite recent efforts to include
patients as stakeholders in guideline development [8, 9],
and no conventional guideline can fully support this
task.
There have been efforts to make clinical guidelines
more accessible to a wider audience, typically by making
them shorter and easier to read. Others want to create
more recognizable knowledge sources for patients
(Table 1). For example, the Wiki Project Med, working
with the Cochrane Collaboration and Wikipedia, has
been recently launched with the aim of giving “free
access to the sum of all medical knowledge” [10]. How-
ever, the production of evidence summaries for patients
is at a very early stage and the public is barely aware
such resources exist [11]. Nevertheless, creating wider
access will not address the core problem.
Guidelines that summarize scientific evidence and pro-
vide recommendations that apply at a general level are
necessary but far from sufficient. Nevertheless, however
much we work to make guidelines readable and access-
ible to a wider audience, they will be limited in their
application to the situations – likely a majority – that
are sensitive to patients’ differing circumstances, prefer-
ences, and priorities. Additional tools are necessary to
ensure that guidelines are optimally applicable – tools
that are just as rigorous when it comes to evidence but
that also help individualize decisions to the patient at
hand. Such tools would compare treatments and make
explicit the tradeoffs between the benefits and harms.
Such tools exist, and have been termed patient decision
support.
Different types of tools
Less well known than guidelines, patient decision sup-
port tools or aids have been developed over the last
few decades. Their goal is to support patients to com-
pare alternative treatment options. Some tools are de-
signed for use by patients before clinical encounters
and other much shorter versions are designed for use
by patients and clinicians together [12, 13]. A sys-
tematic review has shown that these tools have a
positive impact on patient knowledge and risk per-
ception, and often result in significant shifts in
choice of treatment [14]. Despite their benefits, these
interventions have not been widely implemented into
clinical practice [15].
Many of these tools also include information about the
experiences of patients, and describe what it is like to
have the illness and to experience the treatment, includ-
ing side effects. Patients and their families find this kind
of information highly valuable, and as important as un-
derstanding the probabilities of likely outcomes. An ex-
cellent example of this kind of information is the
Healthtalk Online website [16–18]. Patient decision tools
Table 1 Evidence designed for the public: examples of existing efforts
Organizations Activity
Guidelines International Network (GIN) GIN provides advice on how to develop public versions of guidelines,
giving details and guidance about the process [27]
Choosing Wisely collaboration with Consumer Reports, USA Produces evidence-based material that is in part public-facing [28]
Consumers United for Evidence-Based Healthcare (CUE) Some specialty groups in the USA collaborate with CUE to produce
public-facing versions of guidelines, and involve patients in the
development process
The Developing and Evaluating Communication Strategies to Support
Informed Decisions and Practice Based on Evidence Collaboration (DECIDE)
Funded by the European Commission 7th Framework
DECIDE has a work stream on dissemination strategies for clinical
guidelines that are public-facing [29]
The National Institute for Health and Care Excellence (NICE) UK NICE, as well as involving patients as stakeholders, produces plain
English versions of patient guidelines [30]
Scottish Intercollegiate Guidelines Network (SIGN) SIGN produces public-facing versions of clinical guidelines on their
website [31]
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have been widely advocated for facilitating shared deci-
sion making, in which clinicians strive to ensure their
patients are aware of the best evidence available, before
eliciting their preferences. These tools help take
evidence-based medicine to its logical endpoint, to indi-
vidual end-users, where decisions are customized not
only to the characteristics of the individual being treated
but also aligned with their priorities.
Discussion
Towards customized care tools
Whilst we can confidently make the argument for the
adoption of evidence-based tools to help produce cus-
tomized care for individuals, there are many steps re-
quired before this vision becomes a reality. Evidence
synthesis will become more efficient, automated, and
will increase the speed at which tools can be populated
with risk data that can be used at the level of individuals.
There is considerable research published on how to pro-
duce these types of tools and about how to communi-
cate risk that it is understood well by both clinicians and
patients. There are also sources that provide patients
and their families with information about illness and
treatment experience. Bringing these elements together
will be a challenge, and there will be a need to have ver-
sions that can be viewed or used independently as well
as versions that are brief enough for use in clinical
encounters.
How to make these widely accessible is going to be
another significant hurdle. Clinical practice guidelines
have been made available to clinicians by a range of
different arrangements. Patient-facing decision support
tools are not available in the same way, they are avail-
able commercially by a small number of producers, or
are part of research evaluations. Patients and their
families cannot easily find them using Internet search
engines.
Here, then, are some steps that would help us achieve
a future where evidence-based customized care tools
might become more available.
Efficient evidence processing
The work required to locate the highest quality evidence
before producing the best estimates of treatment effects,
burden [19], benefits, and harms takes time and expert-
ise. The methods have, after 40 years of work, been well
developed. The next steps being considered are how to
best automate the process in order to generate faster
data to populate different types of tools.
Sharing experiences
Patients are, of course, interested in more than
evidence-based estimates of risk. They want to know
exactly what they will face as they develop an illness,
and what do other patients say about their experiences
of illness. What are their main concerns, questions,
and priorities [20, 21]? Researchers working with
Healthtalk Online in the UK have summarized the
illness experience of many patients with many condi-
tions [16–18]. More work is required on how best to
integrate this information into tools that can help
customize care.
Tool production
As mentioned, different types of tools will be necessary
to facilitate shared decision making. What ‘matters most
to patients’ should guide the presentation of evidence,
specifically in terms of organizing the content and con-
veying the probabilities of treatment effects, harms, and
burden in ways that communicate risk most effectively.
Short tools such as Issue Cards [12], Option Grids [13],
and SHARE-IT tools [22] have been designed to facili-
tate collaboration and deliberation in clinical encounters
[23]. They do this by being brief and available for both
patient and clinician to use together, either on paper or
tablets. Research efforts are now addressing usability of
tools for the clinical encounter [7, 22, 24]. We argue for
a future state where patients and clinicians rely on
the same evidence base – and on tools that are used
collaboratively – to get to consensus on treatment, where
that is possible. We are working, in collaboration with
many others, to systematize evidence synthesis to facili-
tate the production of trustworthy tools, for multiple
purposes, that can be widely shared (Fig. 1).
Summary
Next steps
The three areas described above – evidence synthesis, pa-
tient experience, and patient-facing tool production – have
Fig. 1 From evidence synthesis to customized care tool production
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stemmed from independent areas of work. There are,
however, signs of increasing overlap between the
groups. A joint conference focusing on shared decision
making and evidence-based healthcare will be held in
Australia in 2015 [25]. Many from the Society for
Participatory Medicine, one of many patient-led orga-
nizations, have attended relevant conferences and are
advocates for these evidence-based patient-facing
tools, and Casey Quinlan, a prominent member, is a
co-author on this article.
Progress will depend on advances in all these areas
if we are to ensure that trustworthy evidence can be
used collaboratively in clinical encounters [23], with
clinicians willing and able to achieve shared decision
making with patients (Box 1). Such tools would in-
clude patients in the development process, and
would move away from the view that medicine has
to be determined solely by ‘what is medically best’
and allow patients’ priorities, concerns, and prefer-
ences to be considered as well [26]. It is time to
move beyond the limitations of current clinical prac-
tice guidelines and focus our energy on tools that
will help facilitate customized care at the level of in-
dividuals and their families.
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